Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lithium: clinical study by brain electrical activity mapping. A case report.

C Beaubernard1, R Minot, J P Macher

  • 1Secteur 8, Centre Hospitalier Spécialisé de Rouffach, France.

Pharmacopsychiatry
|September 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serotonergic and noradrenergic function in depression: clinical correlates.

Dialogues in clinical neuroscience·2011
Same author

Suicidal behavior in schizophrenia and family history of suicide.

Dialogues in clinical neuroscience·2011
Same author

Restless legs syndrome and low brain iron levels in patients with haemochromatosis.

Journal of neurology, neurosurgery, and psychiatry·2005
Same author

A positron emission tomography (PET) study of cerebral dopamine D2 and serotonine 5-HT2A receptor occupancy in patients treated with cyamemazine (Tercian).

Psychopharmacology·2005
Same author

Characterization of the CNS effects of naftidrofuryl (Praxilène) by quantitative EEG and functional MRI: a study in healthy elderly subjects.

Neuropsychobiology·2003
Same author

[Pilot study comparing in blind the therapeutic effect of two doses of agomelatine, melatonin- agonist and selective 5HT2c receptors antagonist, in the treatment of major depressive disorders].

L'Encephale·2003
Same journal

A Tribute to Prof. Jules Angst highlighting his Contributions to Clozapine.

Pharmacopsychiatry·2026
Same journal

Correction: Escitalopram and Clonazepam Affect Gasotransmitter-related Enzyme (nNOS, HO-2, CBS) Gene Expression in the Rat Brain.

Pharmacopsychiatry·2026
Same journal

Correction: Non-Response to Antidepressants: Risk Factors and Therapeutic Possibilities.

Pharmacopsychiatry·2026
Same journal

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2026 - Pharmacokinetic, pharmacogenetic and clinical aspects.

Pharmacopsychiatry·2026
Same journal

Therapeutic Drug Monitoring of Cannabinoids: Therapeutic Reference Ranges for Delta-9-tetrahydrocannabinol in Medical Cannabis, Nabiximols, Dronabinol and Nabilone.

Pharmacopsychiatry·2026
Same journal

A Naturalistic Study on the Cost Reduction and Efficacy of Long-acting Antipsychotics in an Early Intervention Programme for Patients with Recent-onset Psychosis.

Pharmacopsychiatry·2026
See all related articles

This study explores lithium

Area of Science:

  • Neuroscience
  • Psychiatry

Background:

  • Lithium therapy is used for mood disorders.
  • Diurnal effects of lithium monotherapy require further study.
  • Non-invasive brain imaging techniques offer new research avenues.

Observation:

  • Electroencephalography (EEG) mapping can assess diurnal brain activity.
  • Nuclear Magnetic Resonance (NMR) can study lithium's molecular interactions.
  • In vitro studies investigated lithium ion interactions with rat brain tissue and human erythrocyte penetration.

Findings:

  • EEG mapping may reveal mechanisms of lithium action in depression.
  • NMR studies provide insights into lithium's in vitro behavior.
  • Spectroscopic NMR coupled with flame spectrophotometry offers precise lithium measurement.

Related Experiment Videos

Implications:

  • This research could enhance understanding of lithium's therapeutic effects.
  • Advanced imaging techniques may refine treatment strategies for mood disorders.
  • Further investigation into lithium's CNS action is warranted.